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The Surgical Management of Renovascular Hypertension in Children and
Young Adults
R. T. A. Chalmers, A. Dhadwal, J. E. Deal1, P. S. Sever2 and J. H. N. Wolfe*
Regional Vascular Unit, 1Department of Medical Paediatrics and 2Department of Clinical Pharmacology,
St Mary’s Hospital, Praed Street, London, United Kingdom
Objectives: to assess the outcome and durability of operative revascularisation in young patients with renovascular
hypertension.
Design: retrospective study.
Method: the records of all young patients (under 25 years) operated on for renovascular hypertension at St Mary’s
Hospital 1988–1998 were reviewed. We assessed the aetiology of hypertension, operations performed, effect of treatment
on blood pressure, renal function and requirement for antihypertensive medication during follow-up.
Results: ten patients were identified who had been considered for surgery, of median age 16 years (22 months to 22
years). Fibromuscular dysplasia was present in five patients, mid-aortic syndrome (MAS) in four and neurofibromatosis
in one. Operations performed were aortorenal bypass (three), aorto–aortic bypass–renal bypass (three), splenorenal bypass
(one) and autotransplantation (one). Of the three patients treated by balloon angioplasty, only one had a successful result.
One patient with MAS is currently awaiting surgery.
Over a median follow-up of 24 months (8–144), seven patients are normotensive off all antihypertensive medication.
Of two patients on reduced doses of medication, one (splenorenal bypass) required surgical repair of a late (9 years)
coeliac stenosis.
Conclusions: The surgical treatment of renovascular hypertension in carefully selected young patients gives durable
results. Blood pressure is well controlled long-term, and the need for antihypertensive medication is removed altogether
in the majority of patients.
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Introduction with appropriate patient selection, excellent results
can be obtained. Over the years, the exact nature of
Although the majority of young people presenting procedure and conduit have changed as experience
has demonstrated the shortcomings of certain tech-with severe hypertension have renal parenchymal dis-
ease as the underlying aetiology, renovascular prob- niques (for example the use of saphenous-vein grafts
and splenorenal bypass).3lems account for up to 20% of these patients referred
to specialist centres.1 Within this sub-group of patients, We have reviewed our experience in the field of
vascular and endovascular surgery for renovasculara further distinction can be drawn between those who
have vascular disease amenable to intervention (only hypertension in young patients (under 25 years of age)
over the past 10 years.20 of 54 cases reportd by Deal et al.) and those who
do not.2 Thus it is a fairly select cohort of young
patients with renovascular hypertension who can be
considered for surgical revascularisation.
Materials and MethodsThere has been considerable debate about when to
intervene in these patients. A balance has to be drawn
Beteen 1988 and 1998, 10 young people were referredbetween allowance for patient growth and de-
to our unit for consideration of surgical managementvelopment of renal parenchymal loss/end-organ dam-
of renovascular hypertension. There were five malesage. However, the surgical literature indicates that,
and five females of median age 16 years (range: 22
months to 22 years). The mode of presentation was:* Please address all correspondence to: J. H. N. Wolfe, St Mary’s
Hospital, Praed Street, London W2 1NY. asymptomatic hypertension in five patients (detected
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of operation (GC, 9 h) and operative traction-related
left kidney ischaemia (MM).
Three patients underwent percutaneous trans-
luminal balloon dilatation, in two cases for isolated
renal-artery stenosis and in one hypertensive infant
with mid-aortic syndrome (MAS) it was hoped that
balloon dilatation could ‘‘buy some time’’ prior to
definitive surgical intervention. Only one of these in-
terventions was successful. One failed acutely and
emergency surgical revascularisation was necessary
(Fig. 2). The MAS patient had a poor result and had
operative treatment subsequently.
One of the patients in this series, an 8-year-old girl
with MAS associated with renal- and visceral-artery-Fig. 1. Left renal arteriogram showing the typical ‘‘funnel-shaped’’
stenosis associated with neurofibromatosis. origin stenoses (Fig. 3) is currently well controlled on
medication and, in the absence of end-organ damage,
surgical intervention is being delayed to allow for
at routine medical checks), severe headache in three, growth to occur.
hypertensive encephalopathy presenting as fits in one Over a median follow-up of 24 months (range: 8
and intermittent claudication in one. The underlying months to 12 years) seven patients are normotensive
cause of the hypertension was ‘‘fibromuscular dys- on no antihypertensive medication (including the one
plasia’’ in five patients (angiographic diagnosis), mid- successful balloon dilatation), one patient is nor-
aortic syndrome in four and renal artery stenosis in motensive on a reduced dose of antihypertensive med-
association with neurofibromatosis in one (Fig. 1). We ication and one patient (who had a splenoral bypass
did not include patients with arteritis or other acquired nine years previously) re-presented with recurrent
pathology: we wished to study patients with truly hypertension due to the development of a coeliac-
congenital lesions only. Evidence of end-organ damage artery-origin stenosis. This was treated by operative
was present in four at the time of referral (left vent- patch angioplasty with a good result.
ricular hypertrophy in three and hypertensive ret- The median time from surgery to the complete
inopathy in one). All patients had undergone thorough cessation of antihypertensive agents was 6 months
assessment by the referring physician prior to surgery. (range: 0–23 months).
This work-up included clinical examination with fun-
doscopy, serum biochemistry, peripheral plasma renin
and catecholamine levels, electrocardiography and
echocardiography, abdominal ultrasound scan and Discussion
renal isotope scan.2 The isotope scans were performed
with or without the use of angiotensin-converting So-called fibromuscular dysplasia (FMD) and the
enzyme inhibitor drugs according to the preference of ‘‘mid-aortic syndrome’’ (MAS) are the two commonest
the renal physician involved. All patients had pre- causes of surgically-remediable hypertension in the
operative intra-arterial digital subtraction angiography young patient.3 Often multiple stenoses exist sim-
including aortograms in two planes and selective renal ultaneously, affecting distal branch and intrarenal ar-
and visceral views. teries as well as the main renal artery stenoses. Extreme
care is required to ensure that surgery is only under-
taken in appropriate cases.4 Patients with FMD, ostial
and proximal lesions are best treated surgically.5 The
‘‘ideal’’ lesion for balloon dilatation is a short, isolated,Results
non-ostial stenosis.6 The surgical treatment of MAS is
less dependent on the anatomy of the lesion(s) andPatient details, the operations performed, pre- and
postoperative blood pressure and creatinine levels and more dictated by the relative urgency of the operation.
The timing of surgical (and endovascular) inter-follow-up data are shown in Table 1. Renal function
was well preserved in all nine cases. In two (GC and vention is important. Our perception is that the ab-
solute indications for surgery include poor blood-MM) there was a transient rise in creatinine in the
early postoperative period which returned to normal pressure control on high doses of antihypertensive
agents, evidence of end-organ damage (left-ventricularwithin two days. This was attributed to the duration
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Fig. 2. Follow-up aortogram showing right aortorenal graft (arrow)
Fig. 3. Lateral aortogram showing extent of disease in an 8-year-10 years after placement.
old with mid-aortic syndrome. As well as the aortic stenosis (small
arrow), there is a tight stenosis of the superior mesenteric artery
(large arrow).
hypertrophy and hypertensive retinopathy) and evi-
dence of a deterioration in renal function and loss of probably attributable to the underlying aetiology in
their patients being arteritis rather than MAS.renal mass. Relative indications for surgery in this
patient group are poor compliance with medications The largest experience in the surgical management
of paediatric renovascular hypertension comes fromand that the patient has reached an age where only one
definitive operation should be required (particularly Stanley’s group, who have treated 57 patients (age
range: 10 months to 18 years) over the last 30 years.3,9applicable to MAS).
Data in the literature on the outcome of balloon As can be seen from Table 2, this group’s experience
has yielded excellent results and these have beendilatation are limited. In a review of reported cases,
Tegtmeyer identified 25 renal artery angioplasties per- mirrored by those from smaller series from other
centres including our own. In their keynote publicationformed in children with FMD.6 Immediate success was
seen in 92% and, over a median follow-up of 15 in 1995, Stanley and colleagues reviewed their complex
experience and outline how this had led to an evolutionmonths, 18 patients remained normotensive and three
required further intervention. The reported results for of their surgical approach to these patients over the
study period.3 Their view on balloon dilatation andballoon dilatation in renal artery stenosis associated
with neurofibromatosis are not as favourable. Of 12 intraoperative dilatation was that neither of these
methods were appropriate. They stated that, in theirpatients identified by Tegtmeyer, only four reverted to
normotension and two still required antihypertensive opinion, FMD was a misnomer and that, in fact, renal
artery stenosis in affected patients reflected an under-medication.6 However, in six cases balloon dilatation
failed and surgery was necessary. The results of balloon growth of the affected segment of artery. This group
also found that up to 20% of aortorenal vein graftsdilatation in MAS patients are also discouraging. The
exception to this experience is the report by Tyagi et developed severe aneurysmal changes and so they
have changed their practice to the use of internal iliacal. from Delhi.8 The 92% immediate success rate is
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Table 2. Results of published series on outcome of surgery for renovascular hypertension
in young people (adapted from Stanley et al.9).
Outcome of surgery (%)
Institution No. patients Cured Improved Failed
Michigan 57 79 19 2
Cleveland 27 59 19 19
UCLA 26 84 8 4
Vanderbilt 21 68 24 8
Pennsylvania 17 76 24 0
Univ. California 14 86 14 0
St Mary’s 8 88 12 0
artery autografts rather than vein grafts, a practice arteries.3 Furthermore, patients can develop de novo
renal artery stenoses which may or may not be amen-favoured by other authors.10,11 These conduits are far
less prone to dilate over time. The incidence and able to surgical correction.
The surgical treatment of choice for patients withclinical significance of vein-graft dilatation are not
known, but, historically, it has been thought prudent MAS is aortic patchplasty, together with grafts to the
renal arteries as necessary.3 However, in the veryto replace grafts that have been affected. For ostial
lesions, Stanley et al. preferentially re-implant the renal young (and small) patient, a compromise is sometimes
required in the form of aorto–aortic bypass grafting.artery either directly into the aorta or into a neigh-
bouring branch artery. Reoperation on such a patient is a formidable under-
taking, and so allowing growth to occur prior toOther forms of arterial reconstruction have largely
fallen out of favour. Although offering an autogenous definitive surgery seems preferable.15 Clearly, a balance
has to be struck between this approach and com-arterial conduit of reasonable length, from the experi-
ence of Novick et al. amongst others, the splenorenal promise to renal function and end-organs.
In conclusion, we have presented our recent ex-bypass does not perform well in this group of
patients.12 Commonly encountered technical problems perience with the surgical management of re-
novascular hypertension in young patients. Bearing ininclude kinking and early thrombosis. Further, disease
progression in the coeliac artery can compromise the mind that these patients represent a relatively small
sub-group of young people with hypertension, welong-term control of blood pressure, requiring sec-
ondary intervention. This was our experience in the believe that our results are encouraging and reflect
those reported from other centres. With appropriateone patient treated with splenorenal bypass at St
Mary’s. patient selection we can expect a durable result from
surgery and the need for antihypertensive medicationWhilst rarely performed, renal autotransplantation
may be necessary. This approach has been re- is removed altogether.
commended for patients with MAS who are too small
for a definitive aortic operation but in whom renal
function is in jeopardy.13 Combining balloon dilatation
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